Effective anti-viral therapy for hemophagocytic syndrome associated with B-cell lymphoma

Leukemia and Lymphoma

Volumn 44, Issue 10, 2003, Pages 1807-1810

  Gomyo, Hiroshi ^a   Shimoyama, Manabu ^a   Minagawa, Kentaro ^a   Yakushijin, Kimikazu ^a   Urahama, Norinaga ^a   Okamura, Atsuo ^a   Yamamoto, Katsuya ^a   Ito, Mitsuhiro ^a   Chihara, Kazuo ^a   Matsui, Toshimitsu ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acyclovir; Hemophagocytic syndrome; Malignant lymphoma; Methotrexate; Rheumatoid arthritis

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOXORUBICIN; GOLD; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; VINCRISTINE;

AGED; ARTICLE; B CELL LYMPHOMA; BACTERIAL ARTHRITIS; BONE MARROW; CANCER GROWTH; CANCER REGRESSION; CASE REPORT; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG WITHDRAWAL; EPSTEIN BARR VIRUS; FEMALE; HEMOPHAGOCYTIC SYNDROME; HISTIOCYTE; HUMAN; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY TEST; LYMPHOMA; LYMPHOMA CELL; NEUTROPENIA; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SEPTIC SHOCK; SPONDYLITIS; VIRUS INFECTION;

ACYCLOVIR; AGED; ANTIRHEUMATIC AGENTS; ANTIVIRAL AGENTS; ARTHRITIS, RHEUMATOID; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HISTIOCYTOSIS, NON-LANGERHANS-CELL; HUMANS; LYMPHOMA, B-CELL; METHOTREXATE; SYNDROME;

EID: 10744229123     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/1042819031000103926     Document Type: Article

References (27)

1. Shimazaki, C., Inaba, T., Shimura, K., Okamoto, A., Takahashi, R., Hirai, H., Sudo, Y., Ashihara, E., Adachi, Y, Murakami, S., Saigo, K., Fujita, N. and Nakagawa, M. (1999) "B-cell lymphoma associated with haemophagocytic syndrome: a clinical, immunological and cytogenetic study", Br. J. Haematol. 104, 672-679.
2. Imashuku, S. (1997) "Differencial diagnosis of hemophagocytic syndrome: underlying disorders and selection of the most effective treatment", Int. J. Hematol. 66, 135-151.
3. Imasyuku, S., Tabata, Y., Teramura, T. and Hibi, S. (2000) "Treatment strategies for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH)", Leuk. Lymphoma 39, 37-49.
4. Yamanouchi, J., Yamauchi, Y., Yokota, E. and Matsumoto, I. (1998) "Hemophagocytic syndrome in a patient with rheumatoid arthritis", Ryumachi 38, 731-734.
5. Maekawa, M. and Hara, K. (2000) "A case of hemophagocytosis syndrome with excessive Fe and ferritin concentration in serum and with a good prognosis", Jpn. J. Clin. Pathol. 48, 730-733.
6. Onishi, R. and Namiuchi, S. (1994) "Hemophagocytic syndrome in a patient with rheumatoid arthritis", Int. Med. 33, 607-611.
7. Ohno, T., Miyake, N., Hada, S., Hirose, Y., Imura, A., Hori, T., Uchiyama, T., Saiga, T., Mizumoto, T. and Furukawa, H. (1998) "Hemophagocytic syndrome in five patients with Epstein-Barr virus negative B-cell lymphoma", Cancer 82, 1963-1972.
8. Miyahara, M., Sano, M., Shibata, K., Matsuzaki, M., Ibaraki, K., Shimamoto, Y. and Tokunaga, O. (2000) "B-cell lymphoma-associated hemophagocytic syndrome: clinicopathological characteristics", Ann. Hematol. 79, 378-388.
9. Kamel, O.W., van de Rijn, M., Weiss, L.M., Zoppo, G.J., Hench, P.K., Robinns, B.A., Montgomery, P.G., Warnke, R.A. and Dorfman, R.F. (1993) "Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis", N. Engl. J. Med. 328, 1317-1321.
10. van de Rijn, M., Cleary, M.L., Variakojis, D., Warnke, R.A., Chang, P.P. and Kamel, O.W. (1996) "Epstein-Barr virus clonality in lymphomas occurring in patients with rheumatoid arthritis", Arthritis Rheum. 39, 638-642.
11. Georgescu, L. and Paget, S.A. (1999) "Lymphoma in patients with rheumatoid arthritis: what is the evidence of a link with methotrexate?", Drug Saf. 20, 476-487.
12. Mariette, X., Cazals-Hatem, D., Warszawki, J., Liote, F., Balandraud, N. and Siblia, J. (2002) "Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France", Blood 99, 3909-3915.
13. Georgescu, L., Quinn, G.C., Schwarzman, S. and Paget, S.A. (1997) "Lymphoma in patients with rheumatoid arthritis: association with the disease state or methotrexate treatment", Semin. Arthritis Rheum. 26, 794-804.
14. Sibilia, J., Liote, F. and Mariette, X. (1998) "Lymphoproliferative disorders in rheumatoid arthritis patients on low-dose methotrexate", Rev. Rheum. Engl. Ed. 65, 267-273.
15. Hanto, D.W. and Najarian, J.S. (1985) "Advances in the diagnosis and treatment of EBV-associated lymphoproliferative diseases in immunocompromised hosts", J. Surg. Oncol. 30, 215-220.
16. Hanto, D.W., Fizzera, G., Gajl-Peczalska, K.J. and Simmons, R.L. (1985) "Epstein-Barr virus, immunodeficiency and B-cell lymphoproliferation", Transplantation 39, 461-472.
17. Hanto, D.W., Frizzera, G., Gajl-Paczalska, K.J., Sakamoto, K., Purtilo, D.T., Balfour, H.H. Jr, McClain, K., Simmons, R.L. and Najarian, J.S. (1982) "Epstein-Barr virus-induced B-cell lymphoma after renal transplantation", N. Engl. J. Med. 306, 913-918.
18. Sibilia, J., Javier, R.M., Albert, A., Cazenave, J.P. and Kuntz, J.L. (1998) "Pancytopenia secondary to hemophagocytic syndrome in rheumatoid arthritis treated with methotrexate and sulfasalazine", J. Rheumatol. 25, 1218-1220.
19. Reiner, A.P. and Spivak, J.L. (1988) "Hematophagic histiocytosis. A report of 23 new patients and a review of the literature", Medicine (Baltimore) 67, 369-388.
20. Abad, S., Kahn, M.F., Deray, G. and Dubourg, G. (1998) "Hemophagocytic syndrome complicating seronegative rheumatoid polyarthritis: a differential diagnosis of Still's disease?", Rev. Med. Int. 19, 361-362.
21. Vecer, J., Charvat, J., Kubatova, H., Kvapil, M., Hochova, I., Sediva, A. and Bartunkova, J. (2000) "Secondary hemophagocytic syndrome in a systematic disease", Cas. Lek. Cesk. 139, 379-381.
22. Datta, A.K., Colby, B.M., Shaw, J.E. and Pagano, J.S. (1980) "Acyclovir inhibition of Epstein-Barr virus replication", Proc. Natl Acad. Sci. USA 77, 5163-5166.
23. Tosato, G., Steinberg, A.D. and Blauese, R.M. (1981) "Defective EBV-specific suppressor T-cell function in rheumatoid arthritis", N. Engl. J. Med. 305, 1238-1243.
24. Depper, J.M., Bluestein, H.G. and Zvaifler, N.J. (1981) "Impaired regulation of Epstein-Barr virus-induced lymphocyte proliferation in rheumatoid arthritis is due to a T cell defect", J. Immunol. 127, 1899-1902.
25. Stern, R.S., Zierler, S. and Parrish, J.A. (1982) "Methotrexate used for psoriasis and the risk of noncutaneous or cutaneous malignancy", Cancer 50, 869-872.
26. Moder, K.G., Tefferi, A., Cohen, M.D., Menke, D.M. and Luthra, H.S. (1995) "Hematologic malignancies and the use of methotrexate in rheumatoid arthritis: a retrospective study", Am. J. Med. 99, 276-281.
27. Bologna, C., Picot, M.C., Jorgensen, C., Viu, P., Verdier, R. and Sany, J. (1997) "Study of eight cases of cancer in 426 rheumatoid arthritis patients treated with methotrexate", Ann. Rheum. Dis. 56, 97-102.